{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:59:27Z","timestamp":1792799967035,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"DOI":"10.7759\/cureus.53365","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T09:16:45Z","timestamp":1706779005000},"source":"Crossref","is-referenced-by-count":5,"title":["Ketamine in Chronic Pain: A Review"],"prefix":"10.7759","author":[{"given":"Ana","family":"Fa\u00edsco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Dinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e2nia","family":"Seixas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2012.05.012","article-title":"Epidemiology of chronic pain: a population-based nationwide study on its prevalence, characteristics and associated disability in Portugal","volume":"13","author":"Azevedo LF","year":"2012","unstructured":"Azevedo LF, Costa-Pereira A, Mendon\u00e7a L, Dias CC, Castro-Lopes JM. Epidemiology of chronic pain: a population-based nationwide study on its prevalence, characteristics and associated disability in Portugal. J Pain. 2012, 13:773-83. 10.1016\/j.jpain.2012.05.012","journal-title":"J Pain"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1153","article-title":"Ketamine for chronic non-cancer pain: a meta-analysis and trial sequential analysis of randomized controlled trials","volume":"22","author":"Michelet D","year":"2018","unstructured":"Michelet D, Brasher C, Horlin AL, et al.. Ketamine for chronic non-cancer pain: a meta-analysis and trial sequential analysis of randomized controlled trials. Eur J Pain. 2018, 22:632-46. 10.1002\/ejp.1153","journal-title":"Eur J Pain"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup NB","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S, et al.. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015, 14:162-73. 10.1016\/S1474-4422(14)70251-0","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1011512","article-title":"A flood of opioids, a rising tide of deaths","volume":"363","author":"Okie S","year":"2010","unstructured":"Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010, 363:1981-5. 10.1056\/NEJMp1011512","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hup.470050316","article-title":"Neurotransmitters, drugs and disease","author":"Leonard BE","year":"1990","unstructured":"Leonard BE. Neurotransmitters, drugs and disease. Human Psychopharmacology: Clinical and Experimental. Webster R, Jordan C (ed): Blackwell Scientific Publications, Edinburgh; 1990. 5:474. 10.1002\/hup.470050316"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/bjaceaccp\/mkm008","article-title":"Ketamine","volume":"7","author":"Pai A","year":"2007","unstructured":"Pai A, Heining M. Ketamine. CEACCP. 2007, 7:59-63 . 10.1093\/bjaceaccp\/mkm008","journal-title":"CEACCP"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181ed09a2","article-title":"Taming the ketamine tiger. 1965","volume":"113","author":"Domino EF","year":"2010","unstructured":"Domino EF. Taming the ketamine tiger. 1965. Anesthesiology. 2010, 113:678-84. 10.1097\/ALN.0b013e3181ed09a2","journal-title":"Anesthesiology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(03)02192-7","article-title":"Antinociceptive interactions of ketamine with morphine or methadone in mononeuropathic rats","volume":"477","author":"Pelissier T","year":"2003","unstructured":"Pelissier T, Laurido C, Kramer V, Hernandez A, Paeile C. Antinociceptive interactions of ketamine with morphine or methadone in mononeuropathic rats. Eur J Pharmacol. 2003, 477:23-8. 10.1016\/S0014-2999(03)02192-7","journal-title":"Eur J Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/eujp.1999.0154","article-title":"Wind-up and the NMDA receptor complex from a clinical perspective","volume":"4","author":"Eide PK","year":"2000","unstructured":"Eide PK. Wind-up and the NMDA receptor complex from a clinical perspective. Eur J Pain. 2000, 4:5-15. 10.1053\/eujp.1999.0154","journal-title":"Eur J Pain"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(87)90084-0","article-title":"Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro","volume":"26","author":"Smith DJ","year":"1897","unstructured":"Smith DJ, Bouchal RL, deSanctis CA, Monroe PJ, Amedro JB, Perrotti JM, Crisp T. Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro. Neuropharmacology. 1897, 26:1253-60. 10.1016\/0028-3908(87)90084-0","journal-title":"Neuropharmacology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199803000-00029","article-title":"Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells","volume":"88","author":"Nishimura M","year":"1998","unstructured":"Nishimura M, Sato K, Okada T, Yoshiya I, Schloss P, Shimada S, Tohyama M. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology. 1998, 88:768-74. 10.1097\/00000542-199803000-00029","journal-title":"Anesthesiology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF03016530","article-title":"Systemic ketamine inhibits hypersensitivity after surgery via descending inhibitory pathways in rats","volume":"52","author":"Koizuka S","year":"2005","unstructured":"Koizuka S, Obata H, Sasaki M, Saito S, Goto F. Systemic ketamine inhibits hypersensitivity after surgery via descending inhibitory pathways in rats. Can J Anaesth. 2005, 52:498-505. 10.1007\/BF03016530","journal-title":"Can J Anaesth"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI43766","article-title":"Central modulation of pain","volume":"120","author":"Ossipov MH","year":"2010","unstructured":"Ossipov MH, Dussor GO, Porreca F. Central modulation of pain. J Clin Invest. 2010, 120:3779-87. 10.1172\/JCI43766","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/BF00607095","article-title":"The binding of ketamine to plasma proteins: emphasis on human plasma","volume":"24","author":"Dayton PG","year":"1983","unstructured":"Dayton PG, Stiller RL, Cook DR, Perel JM. The binding of ketamine to plasma proteins: emphasis on human plasma. Eur J Clin Pharmacol. 1983, 24:825-31. 10.1007\/BF00607095","journal-title":"Eur J Clin Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/70.6.666","article-title":"Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method","volume":"70","author":"Geisslinger G","year":"1993","unstructured":"Geisslinger G, Hering W, Thomann P, Knoll R, Kamp HD, Brune K. Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. Br J Anaesth. 1993, 70:666-71. 10.1093\/bja\/70.6.666","journal-title":"Br J Anaesth"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.336","article-title":"Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers","volume":"24","author":"Yanagihara Y","year":"2003","unstructured":"Yanagihara Y, Ohtani M, Kariya S, et al.. Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers. Biopharm Drug Dispos. 2003, 24:37-43. 10.1002\/bdd.336","journal-title":"Biopharm Drug Dispos"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/0259-1162.143110","article-title":"Ketamine: current applications in anesthesia, pain, and critical care","volume":"8","author":"Kurdi MS","year":"2014","unstructured":"Kurdi MS, Theerth KA, Deva RS. Ketamine: current applications in anesthesia, pain, and critical care. Anesth Essays Res. 2014, 8:283-90. 10.4103\/0259-1162.143110","journal-title":"Anesth Essays Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-3955(16)38874-5","article-title":"The treatment of critical status asthmaticus in children","volume":"41","author":"DeNicola L","year":"1994","unstructured":"DeNicola L, Monem G, Gayle M, Kissoon N. The treatment of critical status asthmaticus in children. Pediatr Clin North Am. 1994, 41:1293-324. 10.1016\/S0031-3955(16)38874-5","journal-title":"Pediatr Clin North Am"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000160585.43587.5B","article-title":"Revising a dogma: ketamine for patients with neurological injury?","volume":"101","author":"Himmelseher S","year":"2005","unstructured":"Himmelseher S, Durieux ME. Revising a dogma: ketamine for patients with neurological injury?. Anesth Analg. 2005, 101:524-34. 10.1213\/01.ANE.0000160585.43587.5B","journal-title":"Anesth Analg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3171\/2009.1.PEDS08319","article-title":"Effectiveness of ketamine in decreasing intracranial pressure in children with intracranial hypertension","volume":"4","author":"Bar-Joseph G","year":"2009","unstructured":"Bar-Joseph G, Guilburd Y, Tamir A, Guilburd JN. Effectiveness of ketamine in decreasing intracranial pressure in children with intracranial hypertension. J Neurosurg Pediatr. 2009, 4:40-6. 10.3171\/2009.1.PEDS08319","journal-title":"J Neurosurg Pediatr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-013-9950-y","article-title":"The ketamine effect on ICP in traumatic brain injury","volume":"21","author":"Zeiler FA","year":"2014","unstructured":"Zeiler FA, Teitelbaum J, West M, Gillman LM. The ketamine effect on ICP in traumatic brain injury. Neurocrit Care. 2014, 21:163-73. 10.1007\/s12028-013-9950-y","journal-title":"Neurocrit Care"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2015.05.010","article-title":"Ketamine for the treatment of refractory status epilepticus","volume":"30","author":"Fang Y","year":"2015","unstructured":"Fang Y, Wang X. Ketamine for the treatment of refractory status epilepticus. Seizure. 2015, 30:14-20. 10.1016\/j.seizure.2015.05.010","journal-title":"Seizure"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aer221","article-title":"Ketamine: new uses for an old drug?","volume":"107","author":"Hirota K","year":"2011","unstructured":"Hirota K, Lambert DG. Ketamine: new uses for an old drug?. Br J Anaesth. 2011, 107:123-6. 10.1093\/bja\/aer221","journal-title":"Br J Anaesth"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate CA Jr","year":"2006","unstructured":"Zarate CA Jr, Singh JB, Carlson PJ, et al.. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006, 63:856-64. 10.1001\/archpsyc.63.8.856","journal-title":"Arch Gen Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1213\/00000539-197105000-00037","article-title":"Analgesic effects of ketamine administered in subdissociative doses","volume":"50","author":"Sadove M","year":"1971","unstructured":"Sadove M, Shulmman M, Hatano, S, Fevold, N. Analgesic effects of ketamine administered in subdissociative doses. Anesth Analg. 1971, 50:452-7.","journal-title":"Anesth Analg"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1038\/329395a0","article-title":"Taking apart NMDA receptors","volume":"329","author":"Foster A","year":"1987","unstructured":"Foster A, Fagg G. Taking apart NMDA receptors. Nature. 1987, 329:395-6.","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.52965\/001c.25535","article-title":"Ketamine for the treatment of chronic pain: a comprehensive review","volume":"9","author":"Israel JE","year":"2021","unstructured":"Israel JE, St Pierre S, Ellis E, et al.. Ketamine for the treatment of chronic pain: a comprehensive review. Health Psychol Res. 2021, 9:10.52965\/001c.25535","journal-title":"Health Psychol Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68700-X","article-title":"Persistent postsurgical pain: risk factors and prevention","volume":"367","author":"Kehlet H","year":"2006","unstructured":"Kehlet H, Jensen T, Woolf C. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006, 367:1618-25. 10.1016\/S0140-6736(06)68700-X","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(99)00044-5","article-title":"Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes","volume":"82","author":"Schmid R","year":"1999","unstructured":"Schmid R, Sandler A, Katz J. Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes. Pain. 1999, 82:111-25. 10.1016\/S0304-3959(99)00044-5","journal-title":"Pain"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(02)00422-0","article-title":"Opioid-induced abnormal pain sensitivity: Implications in clinical opioid therapy","volume":"100","author":"Mao J","year":"2002","unstructured":"Mao J. Opioid-induced abnormal pain sensitivity: Implications in clinical opioid therapy. Pain. 2002, 100:213-7. 10.1016\/S0304-3959(02)00422-0","journal-title":"Pain"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.12.003","article-title":"Ketamine for chronic non-cancer pain","volume":"141","author":"Bell RF","year":"2009","unstructured":"Bell RF. Ketamine for chronic non-cancer pain. Pain. 2009, 141:210-4. 10.1016\/j.pain.2008.12.003","journal-title":"Pain"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2009.06.023","article-title":"Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1","volume":"145","author":"Sigtermans MJ","year":"2009","unstructured":"Sigtermans MJ, van Hilten JJ, Bauer MC, Arbous SM, Marinus J, Sarton EY, Dahan A. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain. 2009, 145:304-11. 10.1016\/j.pain.2009.06.023","journal-title":"Pain"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2009.08.015","article-title":"Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study","volume":"147","author":"Schwartzman RJ","year":"2009","unstructured":"Schwartzman RJ, Alexander GM, Grothusen JR, Paylor T, Reichenberger E, Perreault M. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain. 2009, 147:107-15. 10.1016\/j.pain.2009.08.015","journal-title":"Pain"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.599721","article-title":"Ketamine use for cancer and chronic pain management","volume":"11","author":"Culp C","year":"2020","unstructured":"Culp C, Kim HK, Abdi S. Ketamine use for cancer and chronic pain management. Front Pharmacol. 2020, 11:10.3389\/fphar.2020.599721","journal-title":"Front Pharmacol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199801000-00015","article-title":"Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations","volume":"88","author":"Bowdle TA","year":"1998","unstructured":"Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology. 1998, 88:82-8. 10.1097\/00000542-199801000-00015","journal-title":"Anesthesiology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2007.00314.x","article-title":"Side effects of ketamine in the long-term treatment of neuropathic pain","volume":"9","author":"Cvrcek P","year":"2008","unstructured":"Cvrcek P. Side effects of ketamine in the long-term treatment of neuropathic pain. Pain Med. 2008, 9:253-7. 10.1111\/j.1526-4637.2007.00314.x","journal-title":"Pain Med"},{"key":"ref37","article-title":"Ketamine: review of its pharmacology and its use in pediatric anesthesia","volume":"46","author":"Bergman S","year":"1999","unstructured":"Bergman S. Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog. 1999, 46:10-20.","journal-title":"Anesth Prog"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0383-6","article-title":"Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy","volume":"55","author":"Peltoniemi MA","year":"2016","unstructured":"Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016, 55:1059-77. 10.1007\/s40262-016-0383-6","journal-title":"Clin Pharmacokinet"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000674","article-title":"Ketamine for pain management","volume":"3","author":"Bell RF","year":"2018","unstructured":"Bell RF, Kalso EA. Ketamine for pain management. Pain Rep. 2018, 3:e674. 10.1097\/PR9.0000000000000674","journal-title":"Pain Rep"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11028.x","article-title":"The prevalence and natural history of urinary symptoms among recreational ketamine users","volume":"110","author":"Winstock AR","year":"2012","unstructured":"Winstock AR, Mitcheson L, Gillatt DA, Cottrell AM. The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int. 2012, 110:1762-6. 10.1111\/j.1464-410X.2012.11028.x","journal-title":"BJU Int"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1981.tb08716.x","article-title":"Liver enzyme studies with continuous intravenous anaesthesia","volume":"36","author":"Blunnie WP","year":"1981","unstructured":"Blunnie WP, Zacharias M, Dundee JW, Doggart JR, Moore J, McIlroy PD. Liver enzyme studies with continuous intravenous anaesthesia. Anaesthesia. 1981, 36:152-6. 10.1111\/j.1365-2044.1981.tb08716.x","journal-title":"Anaesthesia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/227095-ketamine-in-chronic-pain-a-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:15:08Z","timestamp":1707509708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/227095-ketamine-in-chronic-pain-a-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.53365","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}